1. Home
  2. WOK vs SLS Comparison

WOK vs SLS Comparison

Compare WOK & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOK
  • SLS
  • Stock Information
  • Founded
  • WOK 2002
  • SLS 2012
  • Country
  • WOK China
  • SLS United States
  • Employees
  • WOK N/A
  • SLS N/A
  • Industry
  • WOK
  • SLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOK
  • SLS Health Care
  • Exchange
  • WOK NYSE
  • SLS Nasdaq
  • Market Cap
  • WOK 70.3M
  • SLS 70.1M
  • IPO Year
  • WOK 2024
  • SLS N/A
  • Fundamental
  • Price
  • WOK $5.01
  • SLS $1.06
  • Analyst Decision
  • WOK
  • SLS
  • Analyst Count
  • WOK 0
  • SLS 0
  • Target Price
  • WOK N/A
  • SLS N/A
  • AVG Volume (30 Days)
  • WOK 221.3K
  • SLS 1.4M
  • Earning Date
  • WOK 02-03-2025
  • SLS 11-13-2024
  • Dividend Yield
  • WOK N/A
  • SLS N/A
  • EPS Growth
  • WOK N/A
  • SLS N/A
  • EPS
  • WOK N/A
  • SLS N/A
  • Revenue
  • WOK $9,863,642.00
  • SLS N/A
  • Revenue This Year
  • WOK N/A
  • SLS N/A
  • Revenue Next Year
  • WOK N/A
  • SLS N/A
  • P/E Ratio
  • WOK N/A
  • SLS N/A
  • Revenue Growth
  • WOK N/A
  • SLS N/A
  • 52 Week Low
  • WOK $3.26
  • SLS $0.50
  • 52 Week High
  • WOK $8.45
  • SLS $1.72
  • Technical
  • Relative Strength Index (RSI)
  • WOK N/A
  • SLS 55.79
  • Support Level
  • WOK N/A
  • SLS $0.87
  • Resistance Level
  • WOK N/A
  • SLS $1.01
  • Average True Range (ATR)
  • WOK 0.00
  • SLS 0.08
  • MACD
  • WOK 0.00
  • SLS 0.01
  • Stochastic Oscillator
  • WOK 0.00
  • SLS 73.08

About WOK WORK MEDICAL TECHNOLOGY GROUP LTD

WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: